zty
Lv11
40 积分
2023-05-07 加入
-
Oesophageal cancer
5小时前
已完结
-
PCI for Patients with Small Cell Lung Cancer: A New Perspective in the Immunotherapy Era
2天前
求助中
-
Hypofractionated vs Conventionally Fractionated Postmastectomy Radiation After Implant-Based Reconstruction
5天前
已完结
-
Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer
5天前
已完结
-
Design and Rationale for a Phase II/III, Randomized, Double-Blind, Placebo-Controlled Study of Sugemalimab as Consolidation Therapy in Patients With Limited-Stage Small-Cell Lung Cancer Who Have Not Progressed Following Concurrent or Sequential Chemoradiotherapy: The SURPASS Study
5天前
已完结
-
Fertility outcomes post immune checkpoint inhibitor exposure
8天前
已完结
-
Scientific consideration of sex and gender is the responsibility of the many, not the few
8天前
已完结
-
Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial
10天前
已完结
-
Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study
14天前
已完结
-
Real-world comparison of the efficacy and safety of atezolizumab versus durvalumab in extensive-stage small cell lung cancer
23天前
已完结